Page 42 - WNS 2022 Program Book-Final version_Neat
P. 42

A Pediatric Neurosurgery Shunt/Implant Checklist to Reduce Infection
              Risk
              Kelly B Mahaney, MD, MS Department of Neurosurgery Stanford University
              Co-authors :Kevin Kumar, MD, PhD 1 ; Gerald A. Grant, MD 2
              1. Stanford University Department of Neurosurgery
              2. Duke University Department of Neurosurgery
              INTRODUCTION: Shunt infection is a significant contributor to morbidity and
              mortality for children with hydrocephalus. To standardize pediatric neurosurgi-
              cal care and minimize risk of infections related to implanted shunts and neu-
              rosurgical devices, we introduced a 23-point checklist for all pediatric neuro-
              surgical implant procedures at Stanford University in March 2019. Our proto-
              col minimizes operating room traffic and standardizes sterile technique, prep,
              and antibiotic use.
              METHODS: Prospective  quality  initiative  data  obtained from  March  2019 to
              March 2022 was compared with retrospective chart review data of cases from
              March 2016 through February 2019. Checklist compliance was monitored by
              data element. Infections of shunts or implanted devices within 6 months of the
              surgical  date  were  identified  prospectively  and  by  routine  audits.  Infection
              rates  in  the  “Pre-Checklist”  era  were  compared  to  infection  rates  in  the
              “Checklist” era with Fisher’s Exact test.
              RESULTS: Nine implant infections occurred in the 584 “Checklist” era surger-
              ies  (8  shunt  infections,  1  baclofen  pump  infection),  compared  to  4  implant
              infections  that  occurred  in  the  233  “Pre-Checklist”  era  surgeries  (1.5%  vs.
              1.7%, p=0.7677). While we did not observe a reduction in our implant infec-
              tion rate, we maintained a very low implant infection rate during a period of
              significant volume growth. Shunt infections were the most common infections
              observed.  One  baclofen  pump  infection  was  observed  and  no  vagal  nerve
              stimulators, deep brain stimulators, generators, omaya reservoirs, or cranio-
              plasties were infected in the study period. Our observed shunt infection rate
              was 2.6% throughout the study period, with the majority of shunt infections
              occurring in infants under 6 months of age.
              CONCLUSIONS: Adherence to a strict implant protocol can ensure very low
              rates  of  infections  for  pediatric  shunts  and  neurosurgical  implants.  We  ob-
              served a lower shunt infection rate than the national pediatric benchmark –
              the 5-6% infection rate consistently observed by the Hydrocephalus Clinical
              Research Network.




















                                        42
   37   38   39   40   41   42   43   44   45   46   47